Promotion of "Low T" and citation bias in testosterone studies

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 510-511

  Zhao, Jie ^a   Mary Schooling, C ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cardiovascular disease; Citation bias; Testosterone

Indexed keywords

TESTOSTERONE;

ANDROGEN THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CITATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; JOURNAL IMPACT FACTOR; LETTER; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; AGED; CARDIOVASCULAR DISEASES; LITERATURE; MALE; META ANALYSIS (TOPIC); NEEDS ASSESSMENT; PUBLISHING;

AGED; CARDIOVASCULAR DISEASES; HUMANS; JOURNAL IMPACT FACTOR; MALE; META-ANALYSIS AS TOPIC; NEEDS ASSESSMENT; PUBLICATION BIAS; REVIEW LITERATURE AS TOPIC; TESTOSTERONE;

EID: 84933556987     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.010     Document Type: Article

References (10)

1. AndroGel giving AbbVie performance anxietyAvailable from http://www.chicagobusine.com/article/20141122/IUE01/311229982/androgel-givingabbvie-performance-anxiety.
2. Health Canada, Summary safety review-testosterone replacement productscardiovascular riskAvailable from http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/testosterone-eng.php.
3. FDA advisory panel urges restrictions on testosterone useAvailable from http://www.medscape.com/viewarticle/831897#vp-2.
4. EuropeanMedicines Agency, Available from http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2014/04/news-detail-002069.jsp&mid=WC0b01ac058004d5c1.
5. I. Chalmers, M.B. Bracken, B. Djulbegovic, et al., How to increase value and reduce waste when research priorities are set, Lancet 383 (2014) 156-165.
6. L. Xu, G. Freeman, B.J. Cowling, et al., Testosterone therapy and cardiovascular events among men: A systematic review and meta-analysis of placebo-controlled randomized trials, BMC Med. 11 (2013) 108.
7. M.M. Fernandez-Balsells, M.H. Murad, M. Lane, et al., Clinical review 1: Adverse effects of testosterone therapy in adult men: A systematic review and meta-analysis, J. Clin. Endocrinol. Metab. 95 (2010) 2560-2575.
8. J.B. Ruige, A.M. Mahmoud, D. De Bacquer, et al., Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis, Heart 97 (2011) 870-875.
9. R. Swerdloff, B.D. Anawalt, Clinical decisions. Testosterone-replacement therapy, N. Engl. J. Med. 371 (2014) 2032-2034.
10. Advisory Committee Industry Briefing Document, Testosterone replacement therapyAvailable from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM412537.pdf.